You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Possible side effects

This page is specifically for patients who have been prescribed Anoro Ellipta. If you are not a patient please return to the public website.

Like all medicines, Anoro Ellipta can cause side effects, although not everybody will experience them.[1]

If you get immediate breathing difficulties, tightness of the chest, coughing, wheezing or breathlessness immediately after using this medicine: Stop using this medicine and seek medical help immediately, as you may have a serious condition called paradoxical bronchospasm.[1]

If you get eye pain or discomfort, temporary blurring of vision, visual halos or coloured images in association with red eyes during treatment with Anoro Ellipta: Stop using this medicine and seek medical help immediately, these may be signs of an acute attack of narrow-angle glaucoma.[1]

Anoro Ellipta common and non-common side effects

Please see Anoro Ellipta Patient Information Leaflet for full list of possible side effects.


Side effects questions

What do I do if I get a side effect? If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the Anoro Ellipta 55/22mcg patient information leaflet.[1]

References:

  1. Anoro Ellipta 55/22mcg patient information leaflet

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.
By reporting side effects you can help provide more information on the safety of this medicine.

Anoro and Ellipta are registered trademarks of the GlaxoSmithKline group of companies.